desipramine has been researched along with 2-hydroxydesipramine in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 34 (53.97) | 18.7374 |
1990's | 23 (36.51) | 18.2507 |
2000's | 5 (7.94) | 29.6817 |
2010's | 1 (1.59) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldessarini, RJ; Biederman, J; Flood, JG; McDermott, SP; Puopolo, PR; Wilens, TE | 1 |
Barnhill, JG | 1 |
Argenti, D; D'mello, A | 1 |
Danis, M; Dukes, GE; Hak, LJ; Han, YH; Hermann, DJ; Hussey, EK; Krol, TF; Powell, JR | 1 |
Baldessarini, RJ; Biederman, J; Flood, JG; Puopolo, PR; Wilens, TE | 2 |
Cooper, TB; Roose, SP; Suckow, RF | 1 |
Foglia, JP; Perel, JM; Sorisio, D | 1 |
Brøsen, K; Gram, LF; Kragh-Sørensen, P | 1 |
Cooper, TB; Johnson, MH; Nelson, LD; Ribner, HS; Stern, SL; Suckow, RF | 1 |
Cooper, T; Dell, RB; Hein, K; Puig-Antich, J; Ramakrishnan, R | 1 |
Chiba, M; Fujita, S; Suzuki, T | 1 |
Dumont, E; Henthorn, TK; Spina, E; von Bahr, C | 1 |
Bupp, SJ; Preskorn, SH; Weller, EB; Weller, RA | 1 |
Burton, ME; Kenney, JT; Kolodner, RM; Orsulak, PJ | 1 |
Brøsen, K; Gram, LF | 1 |
Atillasoy, E; Jatlow, PI; Mazure, C; Nelson, JC | 1 |
Abrahamsson, T; Carlsson, L | 1 |
Dahlqvist, R; Dumont, E; Spina, E; Steiner, E | 1 |
Cooper, TB; Suckow, RF | 1 |
Jatlow, PI; Mazure, C; Nelson, JC | 1 |
Bech, P; Bertilsson, L; Brøsen, K; Gram, LF; Klysner, R; Otton, SV | 1 |
Jatlow, PI; Nelson, JC | 1 |
Arena, A; Pisani, F; Spina, E | 1 |
Bech, P; Brøsen, K; Gram, LF; Klysner, R | 1 |
Brøsen, K; Gram, LF; Otton, SV | 1 |
Dubbin, JD; Kutcher, SP; Reid, K; Shulman, KI | 1 |
Reed, KL; Stancer, HC | 1 |
Kutcher, SP; Reed, K; Shulman, KI | 1 |
Amsterdam, JD; Brunswick, DJ; Potter, L; Rickels, K; Winokur, A | 1 |
Bock, J; Bowers, MB; Jatlow, PI; Nelson, JC; Quinlan, DM | 1 |
Bock, JL; Gray, S; Jatlow, PI; Nelson, JC | 1 |
DeVane, CL; Jusko, WJ; Sutfin, TA | 1 |
Amsterdam, JD; Brunswick, DJ; Kaplan, MJ; Potter, L | 1 |
Cooke, RG; Persad, E; Reed, KL; Stancer, HC; Warsh, JJ | 1 |
Birgersson, C; Ericsson, O; Mellström, B; Sjöqvist, F; Spina, E; Steiner, E; von Bahr, C | 1 |
Chang, WH; Lane, EA; Potter, WZ; Rudorfer, MV; Zhang, MD | 1 |
Jatlow, PI; Nelson, JC; Price, LH | 1 |
Barkai, AI; Cooper, TB; Suckow, RF | 1 |
Bock, JL; Jatlow, PI; Nelson, JC | 1 |
Bjerre, M; Gram, LF; Kragh-Sørensen, P; Kvinesdal, B; Molin, J; Pedersen, OL; Reisby, N | 1 |
Cutler, NR; Kitanaka, I; Potter, WZ; Ross, RJ; Zavadil, AP | 1 |
Calil, HM; Goodwin, FK; Jusko, WJ; Potter, WZ; Rapoport, J; Sutfin, TA; Zavadil, AP | 1 |
Kramer, PA; McCauley, T; Wong, SH | 1 |
Mahajan, S; Sundaram, K | 1 |
DeVane, CL; Jusko, WJ; Savett, M | 1 |
Beauchamp, G; Elie, R; Lavoie, PA | 1 |
Brøsen, K; Madsen, H; Nielsen, KK | 1 |
Villarreal, G | 1 |
Cotreau-Bibbo, MM; Duan, SX; Greenblatt, DJ; Harmatz, JS; Shader, RI; von Moltke, LL | 1 |
Miescke, KJ; Musa, MN | 1 |
Baker, GB; Coutts, RT; Daneshtalab, M; Su, P | 1 |
Alm, C; Dahl, ML; Ingelman-Sundberg, M; Iselius, L; Johansson, I; Lee, D; Sjöqvist, F; Svensson, JO | 1 |
Avenoso, A; Campo, GM; Caputi, AP; Perucca, E; Spina, E | 1 |
Cooper, TB; Johnson, MH; Nelson, LD; Stern, SL; Suckow, RF | 1 |
Chan, K; Chen, AG; Chen, CN; Chiu, H; Lee, S; Wing, YK | 1 |
Kim, JH; Tluczek, L; Van Dort, ME; Wieland, DM | 1 |
Hirokane, G; Morita, S; Shimoda, K; Someya, T; Takahashi, S; Yokono, A | 1 |
Fotteler, B; Jorga, KM; Modi, M; Rabbia, M | 1 |
Anttila, M; Björklund, H; De Bruyn, S; Hänninen, J; Laine, K; Rouru, J; Scheinin, H | 1 |
Burczynski, ME; Connolly, SM; Fatato, P; Guico-Pabia, C; Isler, JA; Jiang, Q; Nichols, AI; Patroneva, A; Paul, J; Pedersen, R | 1 |
Ahmed, S; Fatato, P; Isler, JA; Jiang, Q; Nichols, AI; Patroneva, A; Paul, J; Pedersen, RD; Shenouda, M | 1 |
Abell, M; Behrle, JA; Chen, Y; Frick, G; Madelyn, A; Nichols, AI; Paul, J | 1 |
11 trial(s) available for desipramine and 2-hydroxydesipramine
Article | Year |
---|---|
Comparison of verapamil, diltiazem, and labetalol on the bioavailability and metabolism of imipramine.
Topics: Administration, Oral; Adolescent; Adult; Antidepressive Agents, Tricyclic; Biological Availability; Desipramine; Diltiazem; Drug Administration Schedule; Drug Interactions; Humans; Imipramine; Labetalol; Male; Verapamil | 1992 |
2-Hydroxydesipramine and desipramine plasma levels and electrocardiographic effects in depressed younger adults.
Topics: Adult; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Depressive Disorder; Desipramine; Electrocardiography; Female; Heart Block; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risk Factors; Single-Blind Method | 1991 |
Steady-state concentrations of imipramine and its metabolites in relation to the sparteine/debrisoquine polymorphism.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Debrisoquin; Depression; Desipramine; Female; Humans; Hydroxylation; Imipramine; Isoquinolines; Kinetics; Male; Middle Aged; Phenotype; Polymorphism, Genetic; Sparteine | 1986 |
The analysis and disposition of imipramine and its active metabolites in man.
Topics: Administration, Oral; Biotransformation; Chromatography, High Pressure Liquid; Desipramine; Humans; Imipramine; Injections, Intramuscular; Kinetics; Male | 1984 |
Desipramine plasma levels and treatment response in panic disorder.
Topics: Desipramine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Panic Disorder; Treatment Outcome | 1995 |
Phenobarbital induces the 2-hydroxylation of desipramine.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Tricyclic; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Debrisoquin; Desipramine; Enzyme Induction; Epilepsy; Half-Life; Humans; Hydroxylation; Male; Mixed Function Oxygenases; Phenobarbital; Phenotype; Polymorphism, Genetic | 1996 |
Effect of tolcapone on the haemodynamic effects and tolerability of desipramine.
Topics: Adult; Antiparkinson Agents; Benzophenones; Cross-Over Studies; Desipramine; Double-Blind Method; Drug Interactions; Drug Tolerance; Female; Hemodynamics; Humans; Levodopa; Male; Nitrophenols; Parkinson Disease; Tolcapone | 2000 |
Effect of the novel anxiolytic drug deramciclane on cytochrome P(450) 2D6 activity as measured by desipramine pharmacokinetics.
Topics: Adult; Analysis of Variance; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Area Under Curve; Camphanes; Cytochrome P-450 CYP2D6; Desipramine; Double-Blind Method; Drug Interactions; Female; Half-Life; Humans; Male; Middle Aged | 2004 |
An assessment of drug-drug interactions: the effect of desvenlafaxine and duloxetine on the pharmacokinetics of the CYP2D6 probe desipramine in healthy subjects.
Topics: Adult; Antidepressive Agents; Area Under Curve; Biotransformation; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP2D6; Desipramine; Desvenlafaxine Succinate; Drug Interactions; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Thiophenes | 2008 |
The effects of desvenlafaxine and paroxetine on the pharmacokinetics of the cytochrome P450 2D6 substrate desipramine in healthy adults.
Topics: Adult; Antidepressive Agents; Area Under Curve; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Desipramine; Desvenlafaxine Succinate; Drug Interactions; Enzyme Inhibitors; Female; Genotype; Humans; Least-Squares Analysis; Male; Middle Aged; Paroxetine; United States; Young Adult | 2009 |
Effects of desvenlafaxine on the pharmacokinetics of desipramine in healthy adults.
Topics: Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Biological Availability; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Desipramine; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Metabolic Detoxication, Phase I; Middle Aged; Neurotransmitter Uptake Inhibitors; Polymorphism, Genetic; Young Adult | 2013 |
52 other study(ies) available for desipramine and 2-hydroxydesipramine
Article | Year |
---|---|
Fluoxetine inhibits desipramine metabolism.
Topics: Attention Deficit Disorder with Hyperactivity; Depressive Disorder; Desipramine; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Retrospective Studies | 1992 |
Plasma desipramine levels and ECG changes in depressed young adults.
Topics: Adult; Alcoholism; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged | 1992 |
Chelation with ferric ions may prevent extraction of 2-hydroxydesipramine from whole blood.
Topics: Chelating Agents; Desipramine; Erythrocytes; Ferric Compounds; Humans | 1992 |
Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged | 1992 |
Effect of fluoxetine on plasma desipramine and 2-hydroxydesipramine.
Topics: Aged; Depressive Disorder; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans | 1992 |
Determination of imipramine, desipramine and their hydroxy metabolites by reversed-phase chromatography with ultraviolet and coulometric detection.
Topics: Chromatography, High Pressure Liquid; Desipramine; Electrochemistry; Humans; Imipramine; Reproducibility of Results; Spectrophotometry, Ultraviolet | 1991 |
Extremely slow metabolism of amitriptyline but normal metabolism of imipramine and desipramine in an extensive metabolizer of sparteine, debrisoquine, and mephenytoin.
Topics: Administration, Oral; Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Chromatography, Thin Layer; Debrisoquin; Desipramine; Drug Interactions; Humans; Imipramine; Male; Mephenytoin; Phenotype; Quinidine; Sparteine | 1991 |
Model for the kinetics of imipramine and its metabolites in adolescents.
Topics: Adolescent; Desipramine; Female; Humans; Imipramine; Male; Models, Biological; Models, Theoretical | 1990 |
Kinetic properties of the metabolism of imipramine and desipramine in isolated rat hepatocytes.
Topics: Animals; Cells, Cultured; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Desipramine; Dose-Response Relationship, Drug; Imipramine; Kinetics; Liver; Male; Rats; Rats, Inbred Strains | 1990 |
In vitro inhibition of a polymorphic human liver P-450 isozyme by narcotic analgesics.
Topics: Analgesics, Opioid; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Humans; Hydroxylation; In Vitro Techniques; Microsomes, Liver; Mixed Function Oxygenases; Polymorphism, Genetic | 1989 |
Plasma levels of imipramine and metabolites in 68 hospitalized children.
Topics: Adolescent; Child; Depressive Disorder; Desipramine; Female; Humans; Imipramine; Male; Psychiatric Department, Hospital | 1989 |
Determination of serum desipramine and 2-hydroxydesipramine for pharmacokinetic applications by HPLC with ultraviolet detection.
Topics: Alkalies; Amitriptyline; Chromatography, High Pressure Liquid; Desipramine; Humans; Microchemistry; Spectrometry, Fluorescence; Time Factors | 1989 |
Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine.
Topics: Adult; Dealkylation; Desipramine; Drug Interactions; Female; Half-Life; Humans; Hydroxylation; Imipramine; Male; Phenotype; Quinidine; Sparteine | 1989 |
Hydroxydesipramine in the elderly.
Topics: Administration, Oral; Aged; Aged, 80 and over; Depressive Disorder; Desipramine; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged | 1988 |
Characterization of the inhibitory effect of some antidepressant drugs on the outward transport of norepinephrine in the ischemic myocardium.
Topics: Animals; Antidepressive Agents; Biological Transport, Active; Chromatography, High Pressure Liquid; Clonidine; Coronary Disease; Desipramine; Fluoxetine; Heart; Isomerism; Lidocaine; Male; Maprotiline; Myocardium; Norepinephrine; Rats; Rats, Inbred Strains | 1988 |
Inhibition of desipramine 2-hydroxylation by quinidine and quinine.
Topics: Adult; Desipramine; Drug Interactions; Female; Humans; Hydroxylation; Male; Quinidine; Quinine | 1988 |
Isolation and identification of the glucuronide conjugate of 2-hydroxydesipramine by preparative liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Desipramine; Humans; Indicators and Reagents; Mass Spectrometry; Spectrophotometry, Ultraviolet | 1988 |
Antidepressant activity of 2-hydroxydesipramine.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Desipramine; Female; Humans; Male; Middle Aged; Prospective Studies; Time Factors | 1988 |
Nonlinear desipramine kinetics: prevalence and importance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Female; Humans; Kinetics; Male; Middle Aged | 1987 |
Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine.
Topics: Adult; Desipramine; Female; Humans; Hydroxylation; Imipramine; Male; Middle Aged | 1987 |
Steady-state levels of imipramine and its metabolites: significance of dose-dependent kinetics.
Topics: Adult; Aged; Biotransformation; Desipramine; Dose-Response Relationship, Drug; Female; Humans; Imipramine; Kinetics; Male; Middle Aged; Phenotype; Time Factors | 1986 |
Imipramine demethylation and hydroxylation: impact of the sparteine oxidation phenotype.
Topics: Adult; Desipramine; Female; Humans; Hydroxylation; Imipramine; Kinetics; Male; Methylation; Oxidation-Reduction; Phenotype; Sparteine | 1986 |
Electrocardiogram changes and therapeutic desipramine and 2-hydroxy-desipramine concentrations in elderly depressives.
Topics: Aged; Depressive Disorder; Desipramine; Electrocardiography; Female; Humans; Male; Middle Aged; Time Factors | 1986 |
Desipramine and 2-hydroxydesipramine in human breast milk and the nursing infant's serum.
Topics: Adult; Breast Feeding; Depressive Disorder; Desipramine; Female; Humans; Infant, Newborn; Kinetics; Milk, Human | 1986 |
Desipramine plasma concentration and therapeutic response in elderly depressives: a naturalistic pilot study.
Topics: Aged; Aged, 80 and over; Depressive Disorder; Desipramine; Dexamethasone; Female; Humans; Hydrocortisone; Male; Middle Aged | 1986 |
Desipramine and 2-hydroxydesipramine plasma levels in endogenous depressed patients. Lack of correlation with therapeutic response.
Topics: Adolescent; Adult; Depressive Disorder; Desipramine; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales | 1985 |
Major adverse reactions during desipramine treatment: relationship to plasma drug concentrations, concomitant antipsychotic treatment, and patient characteristics.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Constipation; Delirium; Depressive Disorder; Desipramine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Mood Disorders; Urination Disorders | 1982 |
Desipramine hydroxylation: variability and effect of antipsychotic drugs.
Topics: Adult; Aged; Antipsychotic Agents; Chromatography, Gas; Chromatography, High Pressure Liquid; Desipramine; Drug Interactions; Female; Humans; Hydroxylation; Male; Middle Aged; Perphenazine | 1983 |
Cimetidine-induced alterations in desipramine plasma concentrations.
Topics: Adult; Biotransformation; Cimetidine; Desipramine; Humans; Middle Aged | 1984 |
The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amitriptyline; Chromatography, High Pressure Liquid; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Female; Humans; Kinetics; Male; Middle Aged; Nortriptyline; Random Allocation | 1984 |
Phenotypic consistency in hydroxylation of desmethylimipramine and debrisoquine in healthy subjects and in human liver microsomes.
Topics: Adult; Chromatography, High Pressure Liquid; Debrisoquin; Desipramine; Female; Humans; Hydroxylation; Isoquinolines; Kinetics; Male; Microsomes, Liver; Middle Aged; Phenotype | 1984 |
Desipramine pharmacokinetics in Chinese and Caucasian volunteers.
Topics: Adult; Asian People; Desipramine; Female; Half-Life; Humans; Hydroxylation; Kinetics; Male; Middle Aged; White People | 1984 |
Effects of desipramine on clinical liver function tests.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Female; Humans; Liver; Liver Function Tests; Male; Middle Aged | 1984 |
Imipramine and its metabolites: relationship to cerebral catecholamines in rats in vivo.
Topics: Animals; Brain; Desipramine; Dopamine; Imipramine; Injections, Intraventricular; Kinetics; Male; Norepinephrine; Rats; Rats, Inbred Strains; Time Factors; Tissue Distribution | 1984 |
Clinical implications of 2-hydroxydesipramine plasma concentrations.
Topics: Depressive Disorder; Desipramine; Drug Evaluation; Humans; Middle Aged; Regression Analysis | 1983 |
Imipramine metabolites in blood of patients during therapy and after overdose.
Topics: Adult; Aged; Chromatography, Thin Layer; Desipramine; Dose-Response Relationship, Drug; Female; Humans; Imipramine; Kinetics; Male; Middle Aged | 1983 |
Altered hydroxydesipramine concentrations in elderly depressed patients.
Topics: Adult; Aged; Aging; Depression; Desipramine; Female; Humans; Kidney; Male; Middle Aged | 1982 |
Active metabolites of imipramine and desipramine in man.
Topics: Adolescent; Adult; Aged; Biotransformation; Child; Desipramine; Double-Blind Method; Enuresis; Female; Humans; Imipramine; Male; Middle Aged | 1982 |
Determination of 2-hydroxydesipramine by high-performance liquid chromatography.
Topics: Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Desipramine; Humans | 1981 |
Theoretical studies on tricyclic antidepressants: III. Analysis of stereospecificity.
Topics: Antidepressive Agents, Tricyclic; Computers; Desipramine; Molecular Conformation; Structure-Activity Relationship | 1981 |
Desipramine and 2-hydroxy-desipramine pharmacokinetics in normal volunteers.
Topics: Adult; Desipramine; Humans; Kinetics; Male | 1981 |
Differential effect of desipramine and 2-hydroxydesipramine on depolarization-induced calcium uptake in synaptosomes from rat limbic sites.
Topics: Animals; Antidepressive Agents, Tricyclic; Calcium; Desipramine; Dose-Response Relationship, Drug; Hippocampus; Male; Rats; Rats, Sprague-Dawley; Synaptosomes | 1995 |
Imipramine metabolism in relation to the sparteine and mephenytoin oxidation polymorphisms--a population study.
Topics: Adult; Chromatography, High Pressure Liquid; Cohort Studies; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Denmark; Desipramine; Female; Genotype; Heterozygote; Homozygote; Humans; Hydroxylation; Imipramine; Male; Mephenytoin; Middle Aged; Mixed Function Oxygenases; Oxidation-Reduction; Oxidoreductases; Polymerase Chain Reaction; Polymorphism, Genetic; Smoking; Sparteine | 1995 |
Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo.
Topics: Animals; Antidepressive Agents; Biotransformation; Desipramine; Drug Interactions; Haplorhini; Humans; Hydroxylation; In Vitro Techniques; Ketoconazole; Male; Mice; Microsomes, Liver; Quinidine; Rats; Selective Serotonin Reuptake Inhibitors; Species Specificity | 1994 |
Pharmacogenetics of desipramine metabolism.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Depressive Disorder; Desipramine; Energy Metabolism; Female; Genotype; Humans; Male; Mathematics; Middle Aged; Pharmacogenetics; Statistics as Topic | 1994 |
Analysis of imipramine and three metabolites produced by isozyme CYP2D6 expressed in a human cell line.
Topics: Catalysis; Cell Line; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Desipramine; Humans; Imipramine; Isoenzymes; Methylation; Mixed Function Oxygenases; Oxidation-Reduction; Recombinant Proteins; Substrate Specificity | 1993 |
Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Child; Depressive Disorder; Desipramine; Electrocardiography; Female; Heart Rate; Humans; Male; Metabolic Clearance Rate; Risk Factors | 1993 |
Polymorphic 2-hydroxylation of desipramine. A population and family study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Child; Debrisoquin; Desipramine; Female; Genetic Linkage; Genotype; Humans; Hydroxylation; Male; Middle Aged; Phenotype; Polymorphism, Genetic; Sweden | 1993 |
2-Hydroxydesipramine and desipramine plasma levels: how are they related to antidepressant response?
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Desipramine; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales | 1996 |
Simultaneous determination of imipramine, desipramine and their 2- and 10-hydroxylated metabolites in human plasma and urine by high-performance liquid chromatography.
Topics: Adult; Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Desipramine; Female; Humans; Imipramine; Male; Middle Aged; Sensitivity and Specificity | 1997 |
Synthesis of 11C-labeled desipramine and its metabolite 2-hydroxydesipramine: potential radiotracers for PET studies of the norepinephrine transporter.
Topics: Carbon Radioisotopes; Carrier Proteins; Desipramine; Isotope Labeling; Norepinephrine Plasma Membrane Transport Proteins; Radiopharmaceuticals; Symporters; Tomography, Emission-Computed | 1997 |
Metabolism of desipramine in Japanese psychiatric patients: the impact of CYP2D6 genotype on the hydroxylation of desipramine.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Asian People; Cytochrome P-450 CYP2D6; Depressive Disorder; Desipramine; Female; Genotype; Humans; Hydroxylation; Japan; Male; Middle Aged | 2000 |